A DOUBLE-BLIND, RANDOMIZED, 6-ARM, PARALLEL-GROUP, DOSE-FINDING, DOUBLE-DUMMY, MULTICENTER COMPARISON OF STNFR55-IGG (RO-45-2081-LENERCEPT [LEN]) SUBCUTANEOUS (SC) TO REFERENCE TREATMENT WITH ORAL METHOTREXATE(MTX) AND THEIR COMBINATION IN PATIENTS WITH RHEUMATOID-ARTHRITIS (RA) (12-WEEK DOSE-FINDING EFFICACY SAFETY STUDY)/
J. Mckay et al., A DOUBLE-BLIND, RANDOMIZED, 6-ARM, PARALLEL-GROUP, DOSE-FINDING, DOUBLE-DUMMY, MULTICENTER COMPARISON OF STNFR55-IGG (RO-45-2081-LENERCEPT [LEN]) SUBCUTANEOUS (SC) TO REFERENCE TREATMENT WITH ORAL METHOTREXATE(MTX) AND THEIR COMBINATION IN PATIENTS WITH RHEUMATOID-ARTHRITIS (RA) (12-WEEK DOSE-FINDING EFFICACY SAFETY STUDY)/, Arthritis and rheumatism, 41(9), 1998, pp. 595-595